Monthly Archives: October 2017
Live-cell imaging revealed the dynamics and the roles of cytoskeleton in polarizing plant zygote
What’s new in the plankton?
Use flat shoes and increase neurogenesis!
When starting to walk the plantarflexor triceps surae muscle is inactivated, the dorsiflexor tibialis anterior activated, and we fall forward because of gravity. The first step is taken, and just as the foot leaves the ground, we
The interaction between diet and gut bacteria in Autism Spectrum Disorder
Metformin and stem cells act synergistically to treat insulin resistance
Fracking is fracturing the total environment of the Earth
Immune damage of Apical Epidermal Cap impedes limb regeneration in frog
Cleaning verification dilemma of manufacturing equipment: Can the analytical method validation fail due to the cleanliness of the stainless steel surfaces?
Understanding vaccine development – Lessons to make effective vaccines against Alzheimer’s disease
Suvorexant, a dual orexin receptor antagonist, may work as a glucose regulatory switch
Intrinsic human multidrug transporters as helpers against Alzheimer’s Disease
The cause(s) of Alzheimer’s Disease (AD) is still unknown, so is a proper method for diagnosis. AD is a widely occurring form of neurodegeneration that is considered to affect 47 million people worldwide, according to the World
We are what we eat, so do aphids
Over one-third of men report perpetrating sexual assault when hooked up to a fake lie detector
New turtle fossils from Uinta Basin represent last documented members of the extensive Baenidae radiation
16th International Pharmaceutical Microbiology and Biotechnology Conference. Vienna, Austria. May 21-23, 2018
2nd Annual Summit on Cell Signaling and Cancer Therapy. Philadelphia, USA. September 19-20, 2018
The broadened spectrum of Fitz-Hugh-Curtis syndrome
5th International Conference and Expo on Computer Graphics & Animation. Montreal, Canada. September 26-27, 2018
New treatments for breast cancer
Now that 90% of women diagnosed with breast cancer will live at least 5 years, new treatments are aim at improving outcomes for the 10% who are not responding to current drugs and delivering treatments with less